COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC:
Get the latest research information from NIH:

Coronavirus Guidance for NIH Applicants and Grantees:

The Hemostasis and Thrombosis (HT) Study Section reviews applications involving basic and applied aspects of the blood and vascular elements associated with hemostasis, thrombosis, and interactions with vasculature. Studies using cellular, biochemical, biophysical, immunological, genetic, pharmacological and molecular biological approaches to define normal and pathological processes are reviewed.

The List of Reviewers lists all present, whether standing members or temporary, to provide the full scope of expertise present on that date. Lists are posted 30 days before the meeting and are tentative, pending any last minute changes.

Review Dates

Membership Panel

The membership panel is a list of chartered members only.


  • Mechanisms of hemostasis, thrombosis and blood coagulation
  • “Omics” of blood cells and plasma proteins that regulate thrombosis and hemostasis.
  • Thrombolysis/fibrinolysis, Plasminogen activation, sepsis, proteases and their receptors
  • Platelet and Megakaryocyte biology, congenital and acquired platelet/bleeding disorders and their gene therapy.
  • Thrombogenesis and coagulation in inflammation/immune response and cancer/uncontrolled tissue growth, acquired coagulopathies.
  • Coagulation factors and platelets in intracranial hemorrhage/clot formation.

Shared Interests and Overlaps

There are shared interests with Vascular Cell and Molecular Biology (VCMB) . Applications which involve the vascular contribution coagulation may be assigned to VCMB. Applications involving coagulation, leukocyte-endothelial interactions, thrombosis, fibrinolysis mechanisms and platelets may be assigned to may be assigned to HT.

There is a shared interest with Atherosclerosis and Inflammation of the Cardiovascular System (AICS) . Applications focused on atherothrombosis in terms of atherosclerotic plaque rupture may be assigned to AICS. Applications that contain other thrombosis- related subjects may be assigned to HT.

There are shared interests with Molecular and Cellular Hematology (MCH) . Applications involving sickle cell disease with a focus on red blood cells may be assigned to MCH. Applications with sickle cell disease involving thrombosis may be assigned to HT.

There are shared interests with Intercellular Interactions (ICI) in cell adhesion. Applications studying cellular interactions through cell adhesion are reviewed in ICI. Applications focused on cell adhesion involved in platelet aggregation and thrombosis are reviewed in HT.

There are shared interests with Surgery, Anesthesiology, and Trauma Study Section (SAT) . Applications involving sepsis may be assigned to SAT. Applications involving sepsis and coagulation may be assigned to HT.

There are shared interests with Brain Injury and Neurovascular Pathologies (BINP) (animal studies) and Acute Neural Injury & Epilepsy (ANIE) (human subject studies). Applications involving the mechanisms of brain injury may be assigned to BINP or ANIE. Applications involving coagulation factors in intracranial hemorrhage/clot formation maybe reviewed in HT.